The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer

Browse by...

Deposit

Highlights

More informations

Title		The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer
Authors		Soria, Francesco Moschini, Marco Haitel, Andrea Wirth, Grégory Johann Gust, Kilian M Briganti, Alberto Rouprêt, Morgan Klatte, Tobias Hassler, Melanie R Karakiewicz, Pierre I Shariat, Shahrokh F show all authors [1 - 11]
Published in		Urologic Oncology. 2016, vol. 34, no. 12, p. 533.e1-533.e10
Abstract		The aim of this study was to evaluate the overexpression of human epidermal growth factor receptor 2 (HER2) in patients with bladder cancer (BCa) and to assess its association with oncological outcomes.
Keywords		Bladder cancer — HER2 — Prognosis — Recurrence — Survival — Target therapy
Identifiers		DOI: 10.1016/j.urolonc.2016.07.006 PMID: 27665356
Full text		Article (Published version) (1.1 MB) - Limited access to UNIGE
Structures		Faculté de médecine / Section de médecine clinique / Département de chirurgie
Research group		Groupe Iselin Christophe (urologie) (106)
Citation (ISO format)		SORIA, Francesco et al. The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer. In: Urologic Oncology, 2016, vol. 34, n° 12, p. 533.e1-533.e10. doi: 10.1016/j.urolonc.2016.07.006 https://archive-ouverte.unige.ch/unige:93723